Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Gastrointestinal Medicine
Volume 2015 (2015), Article ID 939136, 4 pages
http://dx.doi.org/10.1155/2015/939136
Case Report

Recurrent Hepatocellular Carcinoma in Patient with Crohn’s Disease: Incidental or Expected Outcome of Azathioprine?

1Department of Internal Medicine, St. Joseph’s Regional Medical Center, New York Medical College, Paterson, NJ 07503, USA
2Department of Gastroenterology, St. Joseph’s Regional Medical Center, New York Medical College, Paterson, NJ 07503, USA
3Department of Gastroenterology, Joan C. Edwards School of Medicine, Marshall University, Huntington, WV 25755, USA
4Department of General and Hepatobiliary Surgery, St. Joseph’s Regional Medical Center, Paterson, NJ 07503, USA

Received 27 September 2015; Revised 20 November 2015; Accepted 25 November 2015

Academic Editor: Hideto Kawaratani

Copyright © 2015 Youssef Botros et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. M. Parkin, F. Bray, J. Ferlay et al., “Global cancer statistics, 2002,” CA: A Cancer Journal for Clinicians, vol. 55, pp. 74–108, 2005. View at Google Scholar
  2. M.-P. Bralet, J.-M. Régimbeau, P. Pineau et al., “Hepatocellular carcinoma occurring in nonfibrotic liver: epidemiologic and histopathologic analysis of 80 french cases,” Hepatology, vol. 32, no. 2, pp. 200–204, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Askling, P. W. Dickman, P. Karlén et al., “Family history as a risk factor for colorectal cancer in inflammatory bowel disease,” Gastroenterology, vol. 120, no. 6, pp. 1356–1362, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Hemminki, X. Li, J. Sundquist, and K. Sundquist, “Cancer risks in Crohn disease patients,” Annals of Oncology, vol. 20, no. 3, pp. 574–580, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. S. S. Cattan, D. Wendum, O. Chazouilleres, J. Schmitz, and J.-P. Gendre, “Hepatocellular carcinoma and focal hepatic glycogenosis after prolonged azathioprine therapy,” Human Pathology, vol. 31, no. 7, pp. 874–876, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. F. L. Lee, S. M. Murray, J. Prior, and D. R. Shreeve, “Primary liver cell cancer occurring in association with Crohn's disease treated with prednisolone and azathioprine,” Hepato-Gastroenterology, vol. 30, no. 5, article 188, 1983. View at Google Scholar · View at Scopus
  7. M. L. Borum, “Unusual development of hepatocellular carcinoma in a patient with Crohn's disease,” Digestive Diseases and Sciences, vol. 46, no. 10, pp. 2199–2200, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. S. C. Chen, O. W. Cummings, M. P. Hartley, C. A. Filomena, and W. K. Cho, “Hepatocellular carcinoma occurring in a patient with Crohn's disease treated with both azathioprine and infliximab,” Digestive Diseases and Sciences, vol. 51, no. 5, pp. 952–955, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Demarchi, F. Bresso, D. Novero et al., “Hepatocellular carcinoma complicating primary sclerosing cholangitis in Crohn's disease. A case report,” Minerva Gastroenterologica e Dietologica, vol. 53, no. 3, pp. 279–283, 2007. View at Google Scholar
  10. J. Samarasena and M. Borgaonkar, “Development of hepatocellular carcinoma in a patient with Crohn's disease treated with azathioprine,” Digestive Diseases and Sciences, vol. 52, no. 10, pp. 2748–2750, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Miura, T. Kawaguchi, M. Takazoe, S. Kitamura, and H. Yamada, “Hepatocellular carcinoma and Crohn's disease: a case report and review,” Internal Medicine, vol. 48, no. 10, pp. 815–819, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Murakami, Y. Tanaka, M. Ueda et al., “Hepatocellular carcinoma occurring in a young Crohn's disease patient,” Pathology International, vol. 59, no. 7, pp. 492–496, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Ishida, S. Naka, H. Shiomi et al., “Hepatocellular carcinoma occurring in a Crohn's disease patient,” World Journal of Gastroenterology, vol. 16, no. 25, pp. 3215–3218, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. K. J. Fortinsky, A. Alali, K. Jeejeebhoy, S. Fischer, M. Sherman, and S. Fung, “Metastatic hepatocellular carcinoma in a patient with Crohn's disease treated with azathioprine and infliximab: a case report and literature review,” Case Reports in Gastrointestinal Medicine, vol. 2014, Article ID 340836, 4 pages, 2014. View at Publisher · View at Google Scholar
  15. H. Oya, Y. Sato, S. Yamamoto, T. Takeishi, T. Kobayashi, and K. Hatakeyama, “Living related donor liver transplantation for primary sclerosing cholangitis with hepatocellular carcinoma and Crohn's disease: a case report,” Transplantation Proceedings, vol. 36, no. 8, pp. 2297–2298, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. S. H. Jang, J. H. Kim, J. W. Lee et al., “A case of hepatocellular carcinoma in a patient with Crohn's disease,” The Korean Journal of Medicine, vol. 88, no. 4, pp. 424–429, 2015. View at Publisher · View at Google Scholar
  17. J. M. P. A. van den Reek, P. P. M. van Lümig, M. Janssen et al., “Increased incidence of squamous cell carcinoma of the skin after long-term treatment with azathioprine in patients with auto-immune inflammatory rheumatic diseases,” Journal of the European Academy of Dermatology and Venereology, vol. 28, no. 1, pp. 27–33, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. D. S. Kotlyar, J. D. Lewis, L. Beaugerie et al., “Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis,” Clinical Gastroenterology and Hepatology, vol. 13, no. 5, pp. 847.e4–858.e4, 2015. View at Publisher · View at Google Scholar
  19. S. Gruber, L. P. Dehner, and R. L. Simmons, “De novo hepatocellular carcinoma without chronic liver disease but with 17 years of azathioprine immunosuppression,” Transplantation, vol. 43, no. 4, pp. 597–600, 1987. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Russmann, A. Zimmermann, S. Krähenbühl, B. Kern, and J. Reichen, “Veno-occlusive disease, nodular regenerative hyperplasia and hepatocellular carcinoma after azathioprine treatment in a patient with ulcerative colitis,” European Journal of Gastroenterology and Hepatology, vol. 13, no. 3, pp. 287–290, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. N. Arber, G. Zajicek, J. Nordenberg, and Y. Sidi, “Azathioprine treatment increases hepatocyte turnover,” Gastroenterology, vol. 101, no. 4, pp. 1083–1086, 1991. View at Google Scholar · View at Scopus
  22. D. H. Adams and B. Eksteen, “Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease,” Nature Reviews Immunology, vol. 6, no. 3, pp. 244–251, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. J. G. Fox, Y. Feng, E. J. Theve et al., “Gut microbes define liver cancer risk in mice exposed to chemical and viral transgenic hepatocarcinogens,” Gut, vol. 59, no. 1, pp. 88–97, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. S.-M. Zheng, D.-J. Cui, and Q. Ouyang, “Gut-liver axis plays a role in hepatocarcinogenesis of patients with Crohn's disease,” World Journal of Gastroenterology, vol. 17, no. 26, pp. 3171–3172, 2011. View at Publisher · View at Google Scholar · View at Scopus